Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys® pTau-217 test following clearance by the U.S. Food and Drug ...
FierceBiotech

Labcorp adds to drug development, device testing services with Toxikon buy

Already a monolith in the clinical testing space, Labcorp is aiming to further swell its testing capabilities with the acquisition of contract research organization Toxikon. The CRO provides ...

Labcorp's Alzheimer's Disease Blood Test Cleared by FDA

Labcorp (LH) said Monday that its blood test that detects Alzheimer's disease is now available after receiving clearance from the US Food and Drug Administration. The company said its Elecsys pTau-217 ...
Nasdaq

LabCorp (LH) Partners HealthVerity to Grow in Drug Development

Laboratory Corporation of America Holdings or LabCorp LH continues to remain in the headlines with major back-to-back developments within the company’s business. Following last week’s announcement of ...
Nasdaq

LabCorp (LH) Gets FDA Nod for VirSeq SARS-CoV-2 NGS Test

Laboratory Corporation of America Holdings or LabCorp LH recently gained FDA emergency use authorization (EUA) for its VirSeq SARS-CoV-2 NGS (next-generation sequencing) Test on the PacBio Sequel II ...
Business Wire

Labcorp Launches New Test for People With Skin Cancer

BURLINGTON, N.C.--(BUSINESS WIRE)--Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company. The new test ...
Yahoo

Labcorp to offer first FDA-cleared blood test for initial Alzheimer’s disease assessment

Labcorp, one of the country's largest providers of diagnostic medical testing services, announced today that it will offer the only blood test cleared by the U.S. Food and Drug Administration to aid ...